Arman Farr, MD
Retina Specialist · Rock Hill, SCNPI 1962472639
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (37.1%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Cardinal Health 108 LLC at 31.2% of the total. Reporting peaked in 2020 at $1,696 and has fallen 83.4% since, to $282 in 2025.
Across 73 payments — averaging $69.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardinal Health 108 LLC$2K
- Notal Vision, Inc.$1K
- Genentech USA, Inc.$963
- Regeneron Healthcare Solutions, Inc.$300
- Coherus Oncology, Inc.$177
- Cardinal Health 110 LLC$150
- plus $492 from 10 others
What the payments were for
- Consulting fees$1,72534%
- Speaking & faculty fees$1,39228%
- Food & beverage$1,87237%
- Entertainment$601%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardinal Health 108 LLC | 1 | $1,575 |
| Notal Vision, Inc. | 10 | $1,392 |
| Genentech USA, Inc. | 32 | $963 |
| Regeneron Healthcare Solutions, Inc. | 7 | $300 |
| Coherus Oncology, Inc. | 2 | $177 |
| Cardinal Health 110 LLC | 1 | $150 |
| AbbVie(2 entities) | 7 | $133 |
| Sandoz | 3 | $85 |
| Optos, Inc. | 1 | $60 |
| Biogen | 2 | $47 |
| Apellis Pharmaceuticals, Inc. | 2 | $44 |
| Harrow Eye, LLC | 1 | $33 |
| Astellas Pharma US Inc | 1 | $28 |
| Novartis | 1 | $22 |
| Iridex Corporation | 1 | $21 |
| Alimera Sciences, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,049 in reported general payments places this provider in the 75th percentile of 20 retina specialist providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 119 | $4,379 |
| Ketorolac Tromethamine | 28 | $998 |
| Brimonidine Tartrate | 22 | $994 |
| Timolol Maleate | 87 | $924 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 50 | $756 |
| Latanoprost | 18 | $254 |
| Dorzolamide Hcl | 12 | $245 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Rock Hill
- Charles TuckerRock Hill$2K
- Nasrollah SamiyRock Hill$2K
- Hao TangCharleston$66K
- Carl BakerHilton Head Island$37K
- Adam PflugrathGreenville$13K
- Jeffrey GrossColumbia$7K
- Stephen HypesWest Columbia$5K
- James HallGreenville$4K
- Robert PrinziLittle River$4K
- Jeffrey BliceCharleston$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.